Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001962926-26-000006

CHIEF SCIENTIFIC OFFICER acquired 23,634 shares (option exercise)

  • CHIEF SCIENTIFIC OFFICER acquired 23,634 shares (conversion)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-07-14 Option exercise 10b5-1 +23,634 $0.34 $8,036 252,594 D: show line 1 in the form
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-07-14 Conversion 10b5-1 −23,634 228,960 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-07-14 Option exercise · Share Option (right to buy) 10b5-1 −23,634 166,532 D: show line 3 in the form
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-07-14 Conversion · American Depositary Shares 10b5-1 +7,878 7,878 D: show line 4 in the form
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-07-14 Sale · American Depositary Shares 10b5-1 −6,278 $50.80 $318,895 1,600 D: show line 5 in the form
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-07-14 Sale · American Depositary Shares 10b5-1 −1,600 $51.71 $82,734 0 D: show line 6 in the form
Loading xslF345X06/form4-07152026_100751.xml…